Mapping spatially resolved transcriptomes in human and mouse pulmonary fibrosis.
Lovisa FranzénMartina Olsson LindvallMichael HühnVictoria A PtasinskiLaura SetyoBenjamin P KeithAstrid CollinSteven OagThomas VolckaertAnnika BordeJoakim LundebergJulia LindgrenGraham BelfieldSonya JacksonAnna OllerstamMarianna StamouPatrik L StåhlJorrit J HornbergPublished in: Nature genetics (2024)
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis and limited treatment options. Efforts to identify effective treatments are thwarted by limited understanding of IPF pathogenesis and poor translatability of available preclinical models. Here we generated spatially resolved transcriptome maps of human IPF (n = 4) and bleomycin-induced mouse pulmonary fibrosis (n = 6) to address these limitations. We uncovered distinct fibrotic niches in the IPF lung, characterized by aberrant alveolar epithelial cells in a microenvironment dominated by transforming growth factor beta signaling alongside predicted regulators, such as TP53 and APOE. We also identified a clear divergence between the arrested alveolar regeneration in the IPF fibrotic niches and the active tissue repair in the acutely fibrotic mouse lung. Our study offers in-depth insights into the IPF transcriptional landscape and proposes alveolar regeneration as a promising therapeutic strategy for IPF.
Keyphrases
- idiopathic pulmonary fibrosis
- pulmonary fibrosis
- poor prognosis
- transforming growth factor
- interstitial lung disease
- stem cells
- endothelial cells
- single cell
- long non coding rna
- gene expression
- epithelial mesenchymal transition
- transcription factor
- induced pluripotent stem cells
- pluripotent stem cells
- high resolution
- metabolic syndrome
- rna seq
- dna methylation
- systemic sclerosis
- skeletal muscle
- quality improvement
- diabetic rats
- signaling pathway
- high density